Literature DB >> 30514178

Silencing of transgene expression in mammalian cells by DNA methylation and histone modifications in gene therapy perspective.

Suleiman Yusuf Alhaji1,2, Siew Ching Ngai3, Syahril Abdullah1,4.   

Abstract

DNA methylation and histone modifications are vital in maintaining genomic stability and modulating cellular functions in mammalian cells. These two epigenetic modifications are the most common gene regulatory systems known to spatially control gene expression. Transgene silencing by these two mechanisms is a major challenge to achieving effective gene therapy for many genetic conditions. The implications of transgene silencing caused by epigenetic modifications have been extensively studied and reported in numerous gene delivery studies. This review highlights instances of transgene silencing by DNA methylation and histone modification with specific focus on the role of these two epigenetic effects on the repression of transgene expression in mammalian cells from integrative and non-integrative based gene delivery systems in the context of gene therapy. It also discusses the prospects of achieving an effective and sustained transgene expression for future gene therapy applications.

Entities:  

Keywords:  DNA methylation; gene therapy; histone modification; transgene repression

Mesh:

Year:  2018        PMID: 30514178     DOI: 10.1080/02648725.2018.1551594

Source DB:  PubMed          Journal:  Biotechnol Genet Eng Rev        ISSN: 0264-8725


  9 in total

1.  Olfactory receptor coding sequences cause silencing of episomal constructs in multiple cell lines.

Authors:  Ghazia Abbas; Spencer Tang; Joyce Noble; Robert P Lane
Journal:  Mol Cell Neurosci       Date:  2021-11-04       Impact factor: 4.314

2.  Palmitoyl transferases act as potential regulators of tumor-infiltrating immune cells and glioma progression.

Authors:  Feng Tang; Chao Yang; Feng-Ping Li; Dong-Hu Yu; Zhi-Yong Pan; Ze-Fen Wang; Zhi-Qiang Li
Journal:  Mol Ther Nucleic Acids       Date:  2022-05-04       Impact factor: 10.183

3.  Defining Transcription Regulatory Elements in the Human Frataxin Gene: Implications for Gene Therapy.

Authors:  Jixue Li; Yanjie Li; Jun Wang; Trevor J Gonzalez; Aravind Asokan; Jill S Napierala; Marek Napierala
Journal:  Hum Gene Ther       Date:  2020-07-13       Impact factor: 4.793

4.  Induced Pluripotent Stem Cells: Reprogramming Platforms and Applications in Cell Replacement Therapy.

Authors:  Akram Al Abbar; Siew Ching Ngai; Nadine Nograles; Suleiman Yusuf Alhaji; Syahril Abdullah
Journal:  Biores Open Access       Date:  2020-04-28

5.  Epigenetic silencing directs expression heterogeneity of stably integrated multi-transcript unit genetic circuits.

Authors:  Jan Zimak; Zachary W Wagoner; Nellie Nelson; Brooke Waechtler; Hana Schlosser; Morgan Kopecky; Jie Wu; Weian Zhao
Journal:  Sci Rep       Date:  2021-01-28       Impact factor: 4.379

Review 6.  Novel synthetic biology approaches for developmental systems.

Authors:  Christine Ho; Leonardo Morsut
Journal:  Stem Cell Reports       Date:  2021-05-11       Impact factor: 7.765

7.  Epigenetic cell memory: The gene's inner chromatin modification circuit.

Authors:  Simone Bruno; Ruth J Williams; Domitilla Del Vecchio
Journal:  PLoS Comput Biol       Date:  2022-04-06       Impact factor: 4.475

8.  Highly efficient CRISPR-mediated large DNA docking and multiplexed prime editing using a single baculovirus.

Authors:  Francesco Aulicino; Martin Pelosse; Christine Toelzer; Julien Capin; Erwin Ilegems; Parisa Meysami; Ruth Rollarson; Per-Olof Berggren; Mark Simon Dillingham; Christiane Schaffitzel; Moin A Saleem; Gavin I Welsh; Imre Berger
Journal:  Nucleic Acids Res       Date:  2022-07-22       Impact factor: 19.160

9.  The human EF1a promoter does not provide expression of the transgene in mice.

Authors:  Nariman Battulin; Alexey Korablev; Anastasia Ryzhkova; Alexander Smirnov; Evelyn Kabirova; Anna Khabarova; Timofey Lagunov; Irina Serova; Oleg Serov
Journal:  Transgenic Res       Date:  2022-08-12       Impact factor: 3.145

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.